Search results
-
FY24 New Ventures Spotlight
Introducing SJC Bio Image Scott Guelcher, PhD Vanderbilt Professor of Chemical, Biomolecular, and Biomedical Engineering …
-
J. Brennen Carr
Brennen Carr joined CTTC in June 2024, where he focuses on protecting and commercializing technologies in the physical sciences. He brings a diverse background to the team and holds both a PhD in Mechanical Engineering and an MBA from the…
CTTC Admin - 01/21/2025 - 17:20
-
Investors / Entrepreneurs
Investors / Entrepreneurs Stakeholder Resource Finder Links https://cttcventurestudio.com/sites/default…
CTTC Admin - 04/08/2025 - 09:01
-
Vanderbilt CTTC Honors Five Pioneering Faculty as newly-inducted Master Innovators
The Center for Technology Transfer and Commercialization (CTTC) at Vanderbilt proudly announces the 2024 Master Innovator class. This esteemed recognition celebrates the groundbreaking contributions of…
-
Synthetic Methods for Chemo- and Site-selective Bioconjugation in Proteins
… with experimental data on model proteins, reaction sites, conversion rates, and selectivity Out of scope: Uncontrolled reactions at multiple sites Developmental stage of interest: …
CTTC Admin - 04/29/2025 - 13:34
-
Philip Swaney
Philip joined CTTC in August 2016 and is responsible for licensing and market analysis of physical science and engineering technologies. Prior to joining CTTC, Phil was a graduate student at Vanderbilt University in the Medical…
CTTC Admin - 12/24/2024 - 10:41
-
Daiichi Sankyo
Daiichi Sankyo Announcement Date Apr 11, 2025 Strategic Area of Interest for Sponsored Research Modality / Technology Diseases that can be applicable…
valladad - 04/11/2025 - 11:43
-
Benoit Dawant
Title Benoit Dawant Spotlight Caption Benoit Dawant, Ph.D., Cornelius…
CTTC Admin - 10/10/2024 - 09:24
-
Insights and Innovation in Menopause and Perimenopause
Insights and Innovation in Menopause and Perimenopause Announcement Date Mar 18, 2025 Background The menopause transition is a complex physiological process…
valladad - 03/18/2025 - 14:24
-
Innovative Therapies for Genetic Mitochondrial Disorders and Leukodystrophy
Innovative Therapies for Genetic Mitochondrial Disorders and Leukodystrophy Announcement Date Apr 18, 2025 A genetic disease-focused pharmaceutical company is…
CTTC Admin - 04/29/2025 - 13:35